Fulphila
Product Images NDC 67457-833

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Fulphila (NDC 67457-833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Instructions For Use Syringe Before Use (Image 01)

An instructional diagram of the Fulphila prefilled syringe showing labeled parts including the plunger rod, finger grips, label and expiration date, syringe barrel, needle safety guard, needle safety spring, and gray needle cap on the syringe tip.*

FDA Label Image

Instructions For Use Syringe After Use (Image 02)

An illustration showing the components of a used syringe assembly for Fulphila, including the used plunger rod, used syringe barrel, used needle, used needle safety spring, and the gray needle cap removed and displayed separately at the bottom.*

FDA Label Image

Instructions For Use Figure 01 (Image 03)

An instructional illustration showing three items for medical disposal: an adhesive bandage, a cotton ball, and a disposal container with a lid labeled for proper waste disposal. An alcohol wipe is also represented in the illustration as an additional item.*

FDA Label Image

Instructions For Use Figure 02 (Image 04)

An instructional illustration showing a hand holding a prefilled syringe by the designated 'Grab Here' area on the packaging. The image indicates how to correctly grasp the syringe for use.*

FDA Label Image

Instructions For Use Figure 03 (Image 05)

An instructional diagram showing parts of a prefilled syringe for Fulphila including the label, expiration date, medicine chamber, and gray needle cap.*

FDA Label Image

Instructions For Use Figure 04 (Image 06)

An instructional illustration showing recommended injection sites on the body for Fulphila. Labeled areas include the upper arms, stomach area (abdomen), thighs, and on the back view, the upper outer area of the buttocks.*

FDA Label Image

Instructions For Use Figure 05 (Image 07)

An instructional illustration showing hands removing a needle cover from a syringe. The image depicts the proper method for preparing the syringe, with one hand holding the syringe and the other pulling the needle cover upward.*

FDA Label Image

Instructions For Use Figure 06 (Image 08)

An instructional illustration showing a person pinching the skin on their abdomen using thumb and forefinger, demonstrating the proper technique for an injection or subcutaneous administration site.*

FDA Label Image

Instructions For Use Figure 07 (Image 09)

Instructional diagram showing how to use the Fulphila device at 45° and 90° angles for proper administration. The illustration depicts hands positioning the device against the skin with directional arrows indicating motion for application.*

FDA Label Image

Instructions For Use Figure 08 (Image 10)

An instructional illustration showing two hands drawing fluid from a vial with a syringe. One hand holds the vial upside down, while the other pulls back the syringe plunger to withdraw medication. The vial is positioned above the injection site, indicated by an arrow.*

FDA Label Image

Instructions For Use Figure 09 (Image 11)

An instructional illustration showing two hands preparing a prefilled syringe injection. One hand holds the syringe vertically with the thumb pushing the plunger upward, while the other hand rests below, suggesting the injection site preparation on a rounded surface, likely skin.*

FDA Label Image

Fulphila (pegfilgrastim-jmdb) Injection 6 mg/0.6 mL Carton Label (Image 12)

An instructional illustration showing a hand holding a capped vial above a sharps disposal container, with an arrow indicating to dispose of the vial into the container. The drawing emphasizes safe disposal of medical sharps or vials.*

FDA Label Image

Image 13

Packaging label for Fulphila (pegfilgrastim-jmdb) Injection, 6 mg/0.6 mL. The label features the product name, active ingredient, dosage form, and strength prominently in blue and magenta. It includes manufacturer information for Mylan Pharmaceuticals Inc. and distributor details for Mylan Institutional LLC. The label also indicates that it is a single-dose prefilled syringe for subcutaneous use, sterile solution with no preservative, and displays the NDC 67457-833-06 along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.